Global Cancer Consortium Conference

Quanterix is excited to engage with researchers shaping the future of cancer biology.

Quanterix is proud to participate in the 7th Annual Global Cancer Consortium Conference, an international forum advancing collaboration and innovation in cancer research. Hosted by The Hormel Institute, University of Minnesota, from June 12-13, 2026 in Austin, Minnesota. This year’s conference brings together leaders in basic, translational, and clinical oncology to explore the theme “Advances in Metastasis Research.”

Advancing cancer biology through ultrahigh-plex spatial proteomics

At the Global Cancer Consortium Conference, Quanterix will engage with researchers, clinicians, and translational scientists focused on understanding the complex biological mechanisms driving cancer progression, metastasis, and therapeutic response. Together, our spatial biology platforms enable researchers to move seamlessly from ultrahigh-plex biomarker detection to high‑throughput spatial signatures, delivering deep insights into cancer biology.

Why connect with Quanterix?

Conference attendees are invited to connect with us to explore how spatial biology solutions help researchers understand cancer in situ. Our spatial technologies reveal how cells, phenotypes, and pathways interact within complex tumor ecosystems.

Our spatial platforms support research in:

• Tumor heterogeneity and metastatic biology, enabling visualization of distinct cell populations and functional states within intact tissue.
• Immune‑oncology and the tumor microenvironment, mapping immune–tumor interactions that influence progression and therapeutic response.
• Translational cancer research, linking spatial tissue insights with biomarker studies across discovery and development.
• Integrated study strategies, combining spatial tissue data with quantitative protein analysis from blood.

By placing molecular data into spatial context, Quanterix helps researchers generate clear, actionable insights into cancer biology.